Meanwhile, APS inhibited the expression of miR-760 and increased the expression of ankyrin repeat and FYVE domain-containing protein 1 (ANKFY1), ultimately promoting osteogenic maturation and growth of human BMSCs and providing a new therapeutic strategy for osteoporosis. Here, ANKFY1 is linked to osteoporosis.